Glide gets $21M round for drug/device work; Vivus shares battered on weak sales results for Qsymia;

 @FierceBiotech: AstraZeneca claims PhIII sweep for OIC drug as CV concerns linger. News | Follow @FierceBiotech

@JohnCFierce: Officials prepare to dismantle patent rules that stifle drug R&D. Report | Follow @JohnCFierce

@RyanMFierce: Miami biotech Brickell revealed $7M B round for dermatology drug development. Florida a good spot for this company? Release | Follow @RyanMFierce

> The U.K.'s Glide Pharma has completed a £14.0 million ($21.4 million) investment round. Invesco Perpetual led the round with additional support from existing investors. Glide will use the funds to scale up the manufacturing process for the Glide SDI solid dose injector system, which includes both the drug product and device. Release

> Shares of Vivus ($VVUS) took a beating after the company reported that sales of its weight drug Qsymia amounted to only $2 million in the fourth quarter. Story

> The American Association for Clinical Chemistry has tapped Janet B. Kreizman as its new CEO, effective April 1. Release

Medical Device News

 @FierceMedDev: NeuroPace wins FDA panel vote for epilepsy implant. More | Follow @FierceMedDev

 @MarkHFierce: A blood Dx to determine suicide risk? It's possible, and researchers will have a test ready for trials in a year. Story | Follow @MarkHFierce

 @DamianFierce: J&J has to fork over $3.4M in its first vaginal mesh verdict. Roughly 2,100 more lawsuits to go. Report | Follow @DamianFierce

> Abbott lops off another 450 jobs at stent plant. Article

> Mindray milestone: $1B in revenue in 2012. Item

> TearScience wins $70M funding commitment for dry eye device. Story

Pharma News

@FiercePharma: Teva UK pulls batches of generic Clarinex on impurities in tablets. More | Follow @FiercePharma

@EricPFierce: Capsule maker Qualicaps expanding in NC as it transitions to new ownership. News | Follow @EricPFierce

@AlisonBFierce: Dynavax will shoot for a limited approval of hep B vaccine Heplisav. The FDA nixed the product over safety issues. Report | Follow @AlisonBFierce

> Januvia, Byetta double pancreatitis risk, JAMA analysis finds. Story

> With Qsymia sales sputtering, Vivus shares take a dive. News

Biotech Research News

@EmilyMFierce: Retargeted bird virus could provide new treatment for prostate cancer. Story | Follow @EmilyMFierce

> Therapeutic could heal wounds faster. Story

> New drug combo stops head and neck cancer in mice. Report

> Facebook, Google founders award $33M to life scientists. Item

> Obama administration plans brain-mapping project. More

Pharma Manufacturing News

> Teva repeats recall after getting batch numbers wrong. More

> Affymax explores manufacturing for ties to fatal drug reactions. Story

> Qualicaps expanding plant as Mitsubishi takes ownership. News

> Manufacturing continues to undercut Ranbaxy. Article

And Finally… A new study has found that "on any given day" 18% of all men and 11% of all women drink more than federal guidelines recommend. Report

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.